Several randomized trials of graft-versus-host-disease (GVHD) prophylaxis have included methylprednisolone (MP),[1-4][1] but in those studies MP was administered in both study arms in combination with other agents. A trial reported from this institution compared the effect of a combination of
No takes yet. Share an insight, caveat, or question.
Deeg et al. (2000) studied this question.